Absen(SZ:300389) Xin Lang Cai Jing·2025-10-22 00:37Core Insights - The company reported a revenue of 2.872 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 5.66%, and a net profit attributable to shareholders of 185 million yuan, up 57.33% year-on-year [1] - The third quarter of 2025 saw a revenue of 1.053 billion yuan, a year-on-year increase of 14.50%, and a net profit of 69 million yuan, which is a significant year-on-year increase of 138.55% [2] Financial Performance - The gross margin for the first three quarters of 2025 was 31.28%, an increase of 3.13 percentage points year-on-year, with Q3 gross margin at 31.37%, up 2.77 percentage points year-on-year [3] - The operating expense ratio for the first three quarters was 24.24%, a decrease of 1.33 percentage points year-on-year, with specific expense ratios for sales, management, R&D, and finance being 14.20%, 6.07%, 4.41%, and -0.44% respectively [3] Incentive Plan - In September 2025, the company announced a restricted stock incentive plan to grant a total of 12 million shares, approximately 3.25% of the company's total share capital at the time of the announcement [4] - The plan aims to align the interests of shareholders, the company, and the core team, with performance targets set for net profits of no less than 300 million yuan in 2025 and cumulative net profits of 700 million yuan and 1.2 billion yuan for 2025-2026 and 2025-2027 respectively [4] Investment Outlook - Based on the Q3 report, the company adjusted its revenue forecasts for 2025-2027 to 4.028 billion, 4.682 billion, and 5.454 billion yuan, reflecting year-on-year growth rates of 10.0%, 16.2%, and 16.5% respectively [5] - The forecast for net profit attributable to shareholders for 2025-2027 is adjusted to 307 million, 396 million, and 523 million yuan, with year-on-year growth rates of 162.8%, 28.8%, and 32.1% respectively [5] - The expected EPS for 2025-2027 is 0.83, 1.07, and 1.42 yuan, with the stock price on October 21, 2025, at 19.21 yuan, corresponding to PE ratios of 23.08x, 17.92x, and 13.56x [5]